Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

A woman's excess male hormone symptoms were caused by a rare benign tumor in her ovary.

Ancient hair can preserve hormones, revealing health and fertility insights.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

The document did not provide enough information to summarize the causes of hair loss in pre- and postmenopausal women.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Isoflavones may help with menopause symptoms but could be risky for women with hormone-sensitive cancers.

Itraconazole helps improve tough skin infections but may not prevent them from coming back.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Many women experience significant hair loss during menopause, and topical minoxidil is an effective treatment.

Finasteride works for male hair loss only.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Androgens and other hormones affect hair growth and skin conditions like acne.